• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere
• 5. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159829-22-7): A Comprehensive Overview

7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159829-22-7) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique structural features, has shown promising potential in various therapeutic applications. In this article, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the study of this compound.

The molecular structure of 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid is composed of a pyridine ring fused with an imidazole ring, with a chloro substituent at the 7-position and a methyl group at the 2-position. The carboxylic acid functional group at the 3-position adds to its reactivity and potential for forming various derivatives. This unique combination of functional groups contributes to its diverse chemical and biological properties.

In terms of synthesis, several methods have been reported for the preparation of 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid. One common approach involves the condensation of 3-chloropyridine-2-carbaldehyde with guanidine hydrochloride, followed by methylation and carboxylation steps. Another method involves the reaction of 7-chloro-3-methylimidazo[1,2-a]pyridine with carbon dioxide under specific conditions. These synthetic routes have been optimized to improve yield and purity, making the compound more accessible for further research and development.

The biological activities of 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid have been extensively studied in recent years. One of its notable applications is in the field of anticancer research. Studies have shown that this compound exhibits potent antiproliferative effects against various cancer cell lines, including breast cancer, lung cancer, and colon cancer cells. The mechanism of action is believed to involve the inhibition of key signaling pathways such as PI3K/Akt and MAPK/ERK, which are crucial for cell survival and proliferation.

Beyond its anticancer properties, 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid has also shown promise in other therapeutic areas. For instance, it has been investigated for its anti-inflammatory and analgesic effects. Preclinical studies have demonstrated that this compound can effectively reduce inflammation and pain in animal models by modulating cytokine production and inhibiting pro-inflammatory enzymes such as COX-2.

In addition to its direct therapeutic applications, 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid serves as a valuable scaffold for drug discovery. Its structural flexibility allows for the introduction of various functional groups to enhance or modify its biological activities. For example, researchers have synthesized a series of derivatives by substituting different groups at the 6-position of the pyridine ring or by modifying the carboxylic acid moiety. These derivatives have shown improved potency and selectivity in targeting specific biological targets.

The pharmacokinetic properties of 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid are also an important area of investigation. Studies have shown that this compound exhibits favorable absorption, distribution, metabolism, and excretion (ADME) profiles. It has good oral bioavailability and can penetrate biological membranes effectively. However, further optimization may be required to enhance its stability and reduce potential side effects.

In conclusion, 7-Chloro-2-methylimidazo-[1,2-a]pyridine-3-carboxylic acid (CAS No. 1159829-22-7) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for further development as a therapeutic agent. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical uses.

• 21801-79-6(2-Methylimidazo[1,2-a]pyridine-3-carboxylic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)